Global Endowment Management, LP Bristol Myers Squibb CO Transaction History

Global Endowment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $287,545 - $325,841	-4,980 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $245,065 - $319,666	4,980 New	4,980 $320,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $1.57 Million - $1.86 Million	-36,700 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $1.64 Million - $1.81 Million	36,700 New	36,700 $1.67 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $6.46 Million - $7.28 Million	-117,000 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $5.91 Million - $7.37 Million	117,000 New	117,000 $6.47 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Global Endowment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Global Endowment Management, LP with notifications on news.